Concepedia

Uli C. Broedl

UC

90

Publications

28.7K

Citations

56

H-Index

2002

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (United States)

Boehringer Ingelheim (Norway)

University of Toronto

Boehringer Ingelheim (France)

Uli C. Broedl is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and diabetes.

ORCID

Top concepts

Publications per year

2002–2021

90

Publications

90

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 11.6K citations · Full text

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou et al. · Circulation · 2013 · 1.3K citations · Full text

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Ambrish Mithal, Jenny Manassie et al. · The Lancet Diabetes & Endocrinology · 2014 · 567 citations

, , +8

Rows per page

1–5 of 90